Help

Search Results

7 results

  1. TSRC, Tob. Sci. Res. Conf., 2022, 75, abstr. 41

    Intention to purchase multiple e-cigarette flavors and its effect on projected use rate across tobacco user and nonuser groups

    FROST-PINEDA K.(1); POLSTER M.(2); CHAE R.(2); DIANNO N.(2); FREELAND R.(1)
    (1) RAI Services Company, Winston-Salem, NC, USA; (2) Naxion, Philadelphia, PA, USA
    Background: In order for a Premarket Tobacco Application to be authorized, tobacco product manufacturers must provide FDA with scientific evidence to support that a new tobacco product is appropriate for the protection of public health (APPH). FDA...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2021, Online, ST 45

    Meta-analysis study to establish population level estimates of NNAL in smokers and non-smokers

    AYALA-FIERRO F.(1); VERRON T.(2); LIZHNYAK P.(3); FREELAND R.(4); FROST-PINEDA K.(4); ELAMIN A.(5); PRASAD G.L.(4); SARKAR M.(3)
    (1) Juul Labs, Inc, U.S.A.; (2) Imperial Brands, U.K.; (3) Altria Client Services, U.S.A.; (4) RAI Services Company, U.S.A.; (5) Philips Morris International, Switzerland
    The purpose of this research (a project of the CORESTA Biomarkers Sub-Group) was to establish a population level estimate for the biomarker of cigarette smoke exposure, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), to serve as a baseline...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 45

    Meta-analysis of two biomarkers of exposure of tobacco products

    AYALA-FIERRO F.(1); ELAMIN A.(2); FROST-PINEDA K.(3); JIN T.(3); PRASAD G.L.(3); SARKAR M.(4); SCHMIDT E.(3); VERRON T.(5)
    (1) ITG Brands LLC, Greensboro, NC, U.S.A.; (2) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (3) RAI Services Company, Winston-Salem, NC, U.S.A.; (4) Altria Client Services LLC, Richmond, VA, U.S.A.; (5) SEITA - Imperial Brands, Paris, France
    In the context of tobacco products, broadly two types of biomarkers exist, biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH). BoE measure exposure to tobacco constituents, e.g. carbon monoxide (CO) and nicotine equivalents (NEQs)....
  4. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 016

    Beliefs, perceptions, and behavioral intentions related to nicotine, low nicotine cigarettes, and reduced risk products among U.S. adults

    PARMS T.; FROST-PINEDA K.
    RAI Services Company, Winston-Salem, NC, USA
    In March 2018, the U.S. Food and Drug Administration (FDA) published an advance notice of proposed rulemaking to obtain information for consideration in developing a tobacco product standard to set the maximum nicotine level for cigarettes. We...
  5. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 017

    Beliefs and perceptions about nicotine and “minimally addictive” cigarettes among adult current, former, and never smokers

    PARMS T.; FROST-PINEDA K.; CURTIN G.
    RAI Services Company, Winston-Salem, NC, USA
    In March 2018, the US Food and Drug Administration (FDA) issued an advance notice of proposed rulemaking (ANPRM) seeking information on a tobacco product standard potentially lowering nicotine levels in combustible cigarettes. Understanding consumer...
  6. TSRC, Tob. Sci. Res. Conf., 2018, 72, abstr. 012

    Equivalence testing in demonstrating substantial equivalence for new tobacco products

    FROST-PINEDA K.(1); CAMPBELL L.R.(1); POLSTER M.(2); CURTIN G.M.(1)
    (1) RAI Services Company, Winston Salem, NC, USA; (2) Naxion, Philadelphia, PA, USA
    Under Section 905j of the Tobacco Control Act, manufacturers must submit reports to the FDA to demonstrate that a new tobacco product is substantially equivalent (SE) to a “predicate product.” Demonstrating equivalence with traditional statistical...
  7. TSRC, Tob. Sci. Res. Conf., 2017, 71, abstr. 108

    Comprehension and perceptions of reduced risk information for camel snus

    FROST-PINEDA K.(1); PILLITTERI J.(2); SHIFFMAN S.(3); CURTIN G.M.(1)
    (1) RAI Services Company, Winston-Salem, NC, USA; (2) Pinney Associates, Burlington, VT, USA; (3) Pinney Associates, Pittsburgh, PA, USA
    A continuum of risk exists among tobacco products, whereby non-combusted products present less health risks than combusted products. Achieving tobacco harm reduction requires risk information be effectively communicated to consumers, while also...